Cargando…
Myxoma Virus Oncolytic Efficiency Can Be Enhanced Through Chemical or Genetic Disruption of the Actin Cytoskeleton
Myxoma virus (MYXV) is one of many animal viruses that exhibit oncolytic properties in transformed human cells. Compared to orthopoxviruses like vaccinia (VACV), MYXV spreads inefficiently, which could compromise its use in treating tumors and their associated metastases. The VACV F11 protein promot...
Autores principales: | Irwin, Chad R., Favis, Nicole A., Agopsowicz, Kate C., Hitt, Mary M., Evans, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877188/ https://www.ncbi.nlm.nih.gov/pubmed/24391902 http://dx.doi.org/10.1371/journal.pone.0084134 |
Ejemplares similares
-
Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses
por: Irwin, Chad R., et al.
Publicado: (2017) -
Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment
por: Cristi, Francisca, et al.
Publicado: (2023) -
Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti‐tumor immunity with superior safety in bladder cancer models
por: Potts, Kyle G, et al.
Publicado: (2017) -
Radiation-Induced Cellular Senescence Reduces Susceptibility of Glioblastoma Cells to Oncolytic Vaccinia Virus
por: Storozynsky, Quinn T., et al.
Publicado: (2023) -
Oncolytic Virotherapy with Myxoma Virus
por: Rahman, Masmudur M., et al.
Publicado: (2020)